Caris Life Sciences® is at the intersection of science, medicine and information – delivering invaluable data and solutions to biopharma companies and researchers developing the next generation of oncology precision medicines.
Over the past decade, we have amassed linked molecular and therapeutic treatment data from hundreds of thousands of patients, forming a vast data library within the CODEai database to support precision medicine research and development. We innovate novel, proprietary analyses at the forefront of biomarker discovery and molecularly informed drug development using the quality and breadth of real-world treatment and response data. Caris then further translates these innovations into practice through prospectively testing and enabling enrollment into clinical research programs across our vast network.
Designed to maximize the chances of success for clinical trials and address many patient accrual challenges facing biopharma partners in the world of precision medicine.
Our data-driven, molecular insights are changing the landscape of precision medicine with actionable insights from retrospective, epidemiologic, and real-time molecular data to enhance research and commercial activities.
At our 66,000 square foot, state-of-the-art laboratory located in Phoenix, Arizona, we provide high quality, reliable molecular testing services for all stages of the drug development cycle and routine clinical use.
Caris CODEaiTM is a cutting edge data service providing access to real-world integrated molecular and clinical outcomes data. CODEai integrates an extensive database of Caris profiled patient cases with 275,000+ associated outcomes, the most comprehensive data solution in the industry.
Allows for cohort analysis based on: